TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has provided an announcement.
Fusen Pharmaceutical Company Limited has announced the composition of its board of directors and their respective roles, highlighting the leadership structure within the company. The announcement details the membership of three board committees, which are crucial for the company’s governance and operational oversight, potentially impacting its strategic direction and stakeholder engagement.
The most recent analyst rating on (HK:1652) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Fusen Pharmaceutical Co., Ltd. stock, see the HK:1652 Stock Forecast page.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 2,177,365
Technical Sentiment Signal: Buy
Current Market Cap: HK$514.7M
Find detailed analytics on 1652 stock on TipRanks’ Stock Analysis page.

